Viral and histopathologic correlates of MN and MIB-1 expression in cervical intraepithelial neoplasia

Human Pathology

Volumn 27, Issue 3, 1996, Pages 234-239

  Resnick, Murray ^b   Lester, Susan ^b   Tate, James E ^b   Sheets, Ellen E ^b   Sparks, Candace ^b   Crum, Christopher P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

cervical intraepithelial neoplasia; in situ hybridization; Ki 67; MN antigen; papillomaviruses; polymerase chain reaction

Indexed keywords

TUMOR ANTIGEN; TUMOR MARKER;

ANTIGEN EXPRESSION; ARTICLE; CANCER RISK; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN LOCALIZATION; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS REPLICATION; WART VIRUS;

EID: 0029924363     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90062-3     Document Type: Article

References (27)

1. zur Hausen H: Papillomaviruses as carcinomaviruses, in Klein G (ed): Advances in Viral Oncology, New York, NY, Raven, 1989, pp 1-27
2. de Villiers E-M: Heterogeneity of the human papillomavirus group. J Virol 63:4898-4903, 1989
3. Crum CP, Mitao M, Levine RU, et al: Cervical papillomaviruses segregate within morphologically distinct precancerous lesions. J Virol 54:675-681, 1985
4. Kurman RJ, Schiffman MH, Lancaster WD, et al: Analysis of individual human papillomavirus types in cervical neoplasia: A possible role for type 18 in rapid progression. Am J Obstet Gynecol 159:293-296, 1988
5. Lorincz AT, Reid R, Jenson AB, et al: Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types. Obstet Gynecol 79:328-337, 1992
6. McLachlin CM, Tate JE, Zitz JC, et al: Human papillomavirus type 18 and intraepithelial lesions of the cervix. Am J Pathol 144:141-47, 1994
7. Genest DR, Stein L, Cibas E, et al: A binary (Bethesda) system for classifying cervical cancer precursors: Criteria, reproducibility and viral correlates. HUM PATHOL 24:730-736, 1993
8. Robertson AJ, Anderson JM, Swanson Beck J, et al: Observer variability in histological reporting of cervical biopsy specimens. J Clin Pathol 42:231-238, 1989
9. Zavada J, Zavadova Z, Pastorekova S, et al: Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int J Cancer 54:268-273, 1993
10. Liao SY, Brewer C, Zavada J, et al: Identification of the MN antigen as a diagnostic marker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol 145:598-609, 1994
11. McCance DJ, Kopan R, Fuchs E, et al: Human papillomavirus type 16 alters human epithelial differentiation in vitro. Proc Natl Acad Sci U S A 85:7169-7173, 1988
12. Woodworth CD, Bowden PE, Doniger J, et al: Characterization of normal exocervical epithelial cells immortalized in vitro by papillomaviruses types 16 and 18 DNA. Cancer Res 48:4620-4628, 1988
13. Garcia RL, Coltrera MD, Gown AM: Analysis of proliferation grade using anti-PCNA/Cyclin monoclonal antibodies in fixed embedded tissues: Comparison with flow cytometric analysis. Am J Pathol 134:733-739, 1989
14. Cattoretti G, Becker MHG, Key G, et al: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave processed formalin fixed tissues. J Pathol 168:357-364, 1992
15. Konishi I, Fujii S, Nonogaki H, et al: Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix. Cancer 68:1340-1350, 1991
16. Demeter LM, Stoler MH, Broker TR, et al: Induction of proliferating cell nuclear antigen in differentiated keratinocytes of human papillomavirus-infected lesions. HUM PATHOL 25:343-348, 1994
17. Shurbaji MS, Brooks SK, Thurmond TS: Proliferating cell nuclear antigen immunoreactivity in cervical intraepithelial neoplasia and benign cevical epithelium. Am J Clin Pathol 100:22-26, 1993
18. Raju GC: Expression of the proliferating cell nuclear antigen in cervical neoplasia. Int J Gynecol Pathol 13:337-341, 1994
19. Devictor B, Bonnier P, Piana L, et al: c-myc protein and Ki-67 antigen immunodetection in patients with uterine cervix neoplasia: Correlation of microcytophotometric analysis and histological data. Gynecol Oncol 49:284-290, 1993
20. Tervahauta AI, Syrjanen SM, Mantyjarvi R, et al: Detection of p53 protein and Ki-67 proliferation antigen in human papillomavirus positive and negative cervical lesions by immunohistochemical double-staining. Cytoplathology 5:282-293, 1994
21. Mittal KR, Goswami S, Demopolous RI: Proliferating cell nuclear antigen expression in normal and abnormal cervical squamous epithelia. Am J Surg Pathol 17:117-122, 1993
22. Scully RE, Bonfiglio TA, Kurman RJ, et al: Histologic typing of female genital tract tumors (ed 2). New York, NY, Springer-Verlag, 1994, pp 126-128
23. Zitz JC, McLachlin CM, Tate JE, et al: Restriction fragment length polymorphism analysis of isotype-labeled polymerase chain reaction-amplified human papillomavirus DNA combines sensitivity with built-in contaminant detection. Mod Pathol 7:407-411, 1994
24. Manos MM, Ting Y, Wright DK, et al: Use of polymerase chain reaction amplification for the detction of genital human papillomaviruses. Cancer Cells 7:209-1989
25. Lungu O, Wright TC, Silverstein S: Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLR analysis. Mol Cell Probes 6:145-152, 1992
26. Prasad CJ, Sheets E, Selig AM, et al: The binucleate squamous cell: Histologic spectrum and relationship to low-grade squamous intraepithelial lesions. Mod Pathol 6:311-317, 1993
27. Radish AS, Hagan RJ, Ritter DB, et al: Biologic characteristics of specific human papillomavirus types predicted from morphology of cervical lesions. HUM PATHOL 23:2493-2496, 1992